Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Remedy Plan Therapeutics — Funding & Investors." VCBacked, May 13, 2025, https://www.vcbacked.co/company/remedy-plan-therapeutics. Accessed July 1, 2026.
VCBacked. (2025). Remedy Plan Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/remedy-plan-therapeutics
{{cite web |title=Remedy Plan Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/remedy-plan-therapeutics |website=VCBacked |access-date=July 1, 2026}}Profile data sourced and verified per the VCBacked methodology. Last funding round dated .